Information portal on Hereditary Angioedema (HAE)

Printed from www.hae-network.info

This document was printed on 06.Jan.2009.

| To the HAE main menu.
| HAE Range menu .
| To the search.
| Directly to contents.
| To the additional information .


Wikipedia: drug entries

Drug information available on Wikipedia

This list contains weblinks to drug specific entries into the free Wikipedia global encyclopedia. It is frequently updated. Please send us your comments and suggestions by e-mail.

The following websites are operated by other parties. We do not assume any responsibility or liability for the legality, accuracy and completeness of their content.

Wikipedia entry: Androgens

Public domain internet encyclopaedia


Wikipedia
[3/08]: Androgen is the generic term for any natural or synthetic compound, usually a steroid hormone, that stimulates or controls the development and maintenance of masculine characteristics in vertebrates by binding to androgen receptors. This includes the activity of the accessory male sex organs and development of male secondary sex characteristics. Androgens, which were first discovered in 1936, are also called androgenic hormones or testoids. Androgens are also the original anabolic steroids. They are also the precursor of all estrogens, the female sex hormones. The primary and most well-known androgen is testosterone.

Full Wikipedia entry: Androgen

Wikipedia entry: C1-Inhibitor

Public domain internet encyclopaedia


Wikipedia
[3/08]: C1-inhibitor (C1inh) is a serine protease inhibitor (serpin) protein, the main function of which is inhibition of the complement system. It circulates in blood at levels of around 0.25-0.45 g/l. C1-inh is the largest member among the serpin class of proteins. Remarkably, C1-inh has a 2-domain structure, unlike most family members. The serpin domain is similar to other serpins, and this part of C1-inh provides the inhibitory activity of C1-inh. The other domain, named N-terminal domain or N-terminal tail is not essential for C1-inh to inhibit proteinases. This domain has no similarity to other proteins. C1-inh is highly glycosylated glycosylated, bearing both N- and O-glycans. Especially the N-terminal domain is glycosylated heavily.

Full Wikipedia entry: C1-Inhibitor

Wikipedia entry: Danazol

Public domain internet encyclopaedia


Wikipedia
[3/08]: Danazol is a derivative of the synthetic steroid ethisterone, a modified testosterone. Before becoming available as a generic drug, Danazol was marketed as Danocrine in the United States. It was approved by the U.S. Food and Drug Administration (FDA) as the first drug to specifically treat endometriosis in the early 1970s. Although effective for endometriosis, its use is limited by its masculinizing side-effects. Its role as a treatment for endometriosis has been largely replaced by the GnRH agonists.

Full Wikipedia entry: Danazol

Wikipedia entry: Icatibant

Public domain internet encyclopaedia


Wikipedia
[3/08]: Icatibant, a peptidomimetic consisting of ten amino acids, is an effective and specific antagonist of bradykinin B2 receptors. Bradykinin is a peptide-based hormone that is formed locally in tissues, very often in response to a trauma. It increases vessel permeability, dilates blood vessels and causes smooth muscle cells to contract. This hormone plays an important role in the mediation of pain.

Full Wikipedia entry: Icatibant

Wikipedia entry: Stanazolol/Winstrol

Public domain internet encyclopaedia


Wikipedia
[3/08]: Stanozolol, commonly sold under the name Winstrol (oral) and Winstrol Depot (intra-muscular), was developed by Winthrop Laboratories in 1962. It is a synthetic anabolic steroid derived from testosterone, and has been approved by the FDA for human use.

Full Wikipedia entry: Stanazolol/Winstrol

Wikipedia entry: Tranexamic acid

Public domain internet encyclopaedia


Wikipedia
[3/08]: Tranexamic acid (commonly marketed as Cyklokapron in the U.S. and as Transamin in Asia) is often prescribed for excessive bleeding. It is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin, a molecule responsible for the degradation of fibrin. Fibrin is the basic framework for the formation of a blood clot in hemostasis. It has roughly 8 times the antifibrinolytic activity of an older analogue, ε-aminoacaproic acid.

Full Wikipedia entry: Tranexamic acid
Resuming information
Frequently inquired
Author: Jerini AG
Source: HAE-Network
Status: 3/08

This list is frequently updated. Please send us your comments and suggestions by e-mail.

Login

Google Map with HAE-Centres

Google Map with HAE-Centres
The HAE Network website is a free service sponsored by Jerini AG. If you have any questions or comments please contact redaktion@hae-network.info

COPYRIGHT: All rights reserved. Unless otherwise stated, all rights to representations, illustrations and contents on this website rest solely with Jerini AG. Any publication or commercial use without authorization of Jerini AG is strictly forbidden.

NO MEDICAL ADVICE: All information, including opinions and recommendations, on this website is for educational purposes only. Such information is not intended to be a substitute for professional medical advice, diagnosis or treatment. Some parts of this website are provided for the information of health practitioners only. They are accessible via special user ID and password. THESE PARTS ARE NOT INTENDED TO BE USED BY PATIENTS.

NO WARRANTIES OR REPRESENTATIONS:All information on this website is provided without warranty of any kind, expressed or implied. Although Jerini AG makes reasonable efforts to permanently review the content of this website, it may contain errors or inaccuracies. Therefore, Jerini AG is not able to take responsibility for the accuracy, completeness, actuality or fitness for any particular purpose of the information contained herein and will not be liable for any damages or losses which might result from its use.

REFERRALS: Direct or indirect referrals to websites provided by other companies or organizations (in particular, but not limited to, through hyperlinks) do not represent any adaptation of their content. Jerini AG is not able to permanently review these websites and therefore does not take any responsibility for the legality, accuracy and completeness of the content and information on other respective websites.
Please close this window in order to go back to the previous page.
www.hae-network.info

Jerini AG / "HAE - Network" / Invalidenstrasse 130 / 10115 Berlin / Germany